Shopping Cart
Remove All
Your shopping cart is currently empty
SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $30 | - | In Stock | |
| 5 mg | $50 | - | In Stock | |
| 10 mg | $82 | - | In Stock | |
| 25 mg | $166 | - | In Stock | |
| 50 mg | $267 | - | In Stock | |
| 100 mg | $395 | - | In Stock | |
| 200 mg | $557 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $56 | - | In Stock |
| Description | SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5. |
| Targets&IC50 | 5-HT7 receptor:7.5 (pKi) |
| In vitro | SB 258719 antagonised surmountably 5-CT-stimulated adenylyl cyclase activity. Schild analysis of the antagonism by SB 258719 gave a pA2 of 7.2±0.2 and slope not significantly different from 1, consistent with competitive antagonism[3]. |
| In vivo | SB 258719 (5-20 mg/kg, i.p.) reversed the hypothermic effect of 5-CT in mice[1], attenuated increased Wnt/β-catenin activity in HCC cell lines and patient-derived primary tumor tissues in the presence of 5-HT, and reduced tumor growth in vivo[2]. |
| Molecular Weight | 338.51 |
| Formula | C18H30N2O2S |
| Cas No. | 195199-95-2 |
| Smiles | C[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c1cccc(C)c1 |
| Relative Density. | 1.075 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (738.53 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (14.77 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.